Industry News
Vic Uni to test forensic DNA tools
A collaboration between researchers at Victoria University, the Victorian Forensic Science Centre (VFSC) and US genomics company DNAPrint Genomics will test DNAPrint's Retinome assay for iris colour for use in Australia. [ + ]
New theory tests limits to complexity
Functionally, the genomes of humans and other higher life forms have more in common with the intricate circuitry of a computer processor chip than with the simple genomes of bacteria, according to a new theory advanced by Australian researchers. [ + ]
'Laboratory of the Year' competition
What's New Magazines and Science Industry Australia Inc (SIA) invite entries to the Laboratory of the Year Competition.
[ + ]Ausbiotech says WA govt biased against GM
Australian biotechnology's peak body, AusBiotech, has questioned the impartiality of Western Australia's agricultural minister Kim Chance in relation to GM crops, following the release of correspondence between the government and activitist GM groups. [ + ]
Mayne cops FDA warning
Mayne Pharma, the pharmaceuticals division of the Mayne group (ASX: MAY) has received a rap over the knuckles from the US FDA for failing to adequately report adverse events resulting from use of its drug products. [ + ]
Financial results: Meditech and Optiscan
Meditech Research (ASX: MTR) has reported that its revenues increased 90 per cent to AUD$679,495 while its net loss decreased marginally to $2.7 million during its financial year ending December 31, 2004. [ + ]
Making super-sensitive antibodies with help from camels and sharks
What do camels and sharks have in common? A remarkable, binary immune system that quells viruses and other infectious nasties with an efficiency that the human immune system cannot match, according to CSIRO molecular immunologist Dr Peter Hudson. [ + ]
Takeda buys US drug-developer Syrxx
Japanese pharmaceutical giant Takeda has paid US$270 million in cash to acquire Syrxx, a private drug-development company based in San Diego. [ + ]
Tissue therapies posts small loss
Tissue Therapies Limited (ASX:TIS) has released its half-year results, recording a net loss of $445,400, in line with budget expectations. [ + ]
Gribbles JV finds smart ways to tag and track DNA
New joint venture company, id-DNA, formed by Gribbles Molecular Science (GMS) and Sunshine Technologies (ST), has big plans for its latest tracking technology, which will combine DNA fingerprinting with radio frequency identification tags. [ + ]
Experimental use of patents may be re-invented
One of the legal myths of scientific research -- that using a patented invention is OK as long as that use is only experimental not commercial -- might just become reality later this year. [ + ]
Board briefs: Neuren; Peptech; Cytopia
Executives with US experience and contacts in the international equities market remain as popular as ever amongst Australian biotechs, if this week's board appointments are anything to go by. [ + ]
NZ's Protemix recruits US-based CEO
Biotech entrepreneur Garth Cooper has stepped sideways from his role as CEO of New Zealand biotech Protemix, appointing US-based former Eli Lilly executive Larry Ellingson to guide the company through pending Phase III trials of its drug for diabetic heart disease Laszarin. [ + ]
Acrux gets results in libido trial
Acrux (ASX: ACR) has reported positive results from the Phase IIb trial of its testosterone MDTS spray in pre-menopausal women with low libido. [ + ]
Becalmed Pfizer reviewing company operations, plans job cuts
Pfizer, faced with slowing earnings growth, and safety concerns that have hurt demand for its arthritis products, is conducting a comprehensive review of its operations and is considering job cuts. [ + ]

